Kite Lake Capital Management (Uk) LLP Pacific Biosciences Of California, Inc. Transaction History

Kite Lake Capital Management (Uk) LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $6.91 Million - $18.8 Million	-658,092 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.61 - $9.87 $12.1 Million - $33 Million	-3,340,002 Reduced 83.54%	658,092 $6.5 Million
Q2 2020 Aug 14, 2020	SELL	$2.65 - $4.03 $3.96 Million - $6.02 Million	-1,492,900 Reduced 27.19%	3,998,094 $13.8 Million
Q1 2020 May 15, 2020	BUY	$2.36 - $5.26 $13 Million - $28.9 Million	5,490,994 New	5,490,994 $16.8 Million
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $17 Million - $20.6 Million	-3,689,527 Closed	0 $0
Q3 2019 Mar 10, 2020	BUY	$4.99 - $6.16 $18.4 Million - $22.7 Million	3,689,527 New	3,689,527 $19 Million
Q3 2019 Nov 14, 2019	SELL	$4.99 - $6.16 $17.5 Million - $21.6 Million	-3,503,293 Closed	0 $0
Q2 2019 Mar 10, 2020	BUY	$5.92 - $7.41 $20.7 Million - $26 Million	3,503,293 New	3,503,293 $21.2 Million
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $15.3 Million - $19.1 Million	-2,580,021 Closed	0 $0
Q1 2019 Mar 10, 2020	BUY	$6.8 - $7.4 $17.5 Million - $19.1 Million	2,580,021 New	2,580,021 $18.7 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Kite Lake Capital Management (Uk) LLP, based on Form 13F filings with the SEC.

Stay updated on Kite Lake Capital Management (Uk) LLP with notifications on news.